Rho/ROCK/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells

Experimental Cell Research

Volumn 314, Issue 17, 2008, Pages 3162-3174

  Papadopoulou, Natalia ^a   Charalampopoulos, Ioannis ^a   Alevizopoulos, Konstantinos ^b   Gravanis, Achille ^a   Stournaras, Christos ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b Medexis Biotech SA   (Greece)

Author keywords

Actin dynamics; Apoptosis; mAR activation; Prostate cancer; Rho GTPase signaling

Indexed keywords

ACTIN; ACTIN DEPOLYMERIZING FACTOR; ANDROGEN RECEPTOR; BOVINE SERUM ALBUMIN; HORMONE RECEPTOR BLOCKING AGENT; LIM DOMAIN KINASE 2; LIM PROTEIN; MEMBRANE RECEPTOR; PROTEIN CDC42; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION;

EID: 53249107178     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.07.012     Document Type: Article

References (50)

1. Beato M. Gene regulation by steroid hormones. Cell 56 (1989) 335-344
2. Falkenstein E., Norman A.W., and Wehling M. Mannheim classification of nongenomically initiated (rapid) steroid action(s). J. Clin. Endocrinol. Metab. 85 (2000) 2072-2075
3. Koukouritaki S.B., Theodoropoulos P., Margioris A.N., Gravanis A., and Stournaras C. Dexamethasone alters rapidly actin polymerization dynamics in human endometrial cells: evidence for nongenomic actions involving cAMP turnover. J. Cell. Biochem. 62 (1996) 251-261
4. Koukouritaki S.B., Gravanis A., and Stournaras C. Tyrosine phosphorylation of focal adhesion kinase and paxillin regulates the signaling mechanism of the rapid nongenomic action of dexamethasone on actin cytoskeleton. Mol. Med. 5 (1999) 731-742
5. Powell C.E., Watson C.S., and Gametchu B. Immunoaffinity isolation of native membrane glucocorticoid receptor from S-49++ lymphoma cells: biochemical characterization and interaction with Hsp 70 and Hsp 90. Endocrine 10 (1999) 271-280
6. Evans S.J., Murray T.F., and Moore F.L. Partial purification and biochemical characterization of a membrane glucocorticoid receptor from an amphibian brain. J. Steroid Biochem. Mol. Biol. 72 (2000) 209-221
7. Zhu Y., Bond J., and Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2237-2242
8. Zhu Y., Rice C.D., Pang Y., Pace M., and Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2231-2236
9. Chambliss K.L., Yuhanna I.S., Anderson R.G., Mendelsohn M.E., and Shaul P.W. ERbeta has nongenomic action in caveolae. Mol. Endocrinol. 16 (2002) 938-946
10. Song R.X., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R., and Santen R.J. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol. Endocrinol. 16 (2002) 116-127
11. Benten W.P., Lieberherr M., Giese G., Wrehlke C., Stamm O., Sekeris C.E., Mossmann H., and Wunderlich F. Functional testosterone receptors in plasma membranes of T cells. FASEB J. 13 (1999) 123-133
12. Benten W.P., Lieberherr M., Stamm O., Wrehlke C., Guo Z., and Wunderlich F. Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol. Biol. Cell 10 (1999) 3113-3123
13. Kampa M., Papakonstanti E.A., Hatzoglou A., Stathopoulos E.N., Stournaras C., and Castanas E. The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. FASEB J. 16 (2002) 1429-1431
14. Charalampopoulos I., Alexaki V.I., Lazaridis I., Dermitzaki E., Avlonitis N., Tsatsanis C., Calogeropoulou T., Margioris A.N., Castanas E., and Gravanis A. G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB J. 20 (2006) 577-579
15. Frye C.A. The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res. Brain Res. Rev. 37 (2001) 201-222
16. Monnet F.P., and Maurice T. The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. J. Pharmacol. Sci. 100 (2006) 93-118
17. Kampa M., and Castanas E. Membrane steroid receptor signaling in normal and neoplastic cells. Mol. Cell. Endocrinol. 246 (2006) 76-82
18. Losel R., and Wehling M. Nongenomic actions of steroid hormones. Nat. Rev., Mol. Cell. Biol. 4 (2003) 46-56
19. Norman A.W., Mizwicki M.T., and Norman D.P. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat. Rev. Drug Discov. 3 (2004) 27-41
20. Hatzoglou A., Kampa M., Kogia C., Charalampopoulos I., Theodoropoulos P.A., Anezinis P., Dambaki C., Papakonstanti E.A., Stathopoulos E.N., Stournaras C., Gravanis A., and Castanas E. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J. Clin. Endocrinol. Metab. 90 (2005) 893-903
21. Papakonstanti E.A., Kampa M., Castanas E., and Stournaras C. A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Mol. Endocrinol. 17 (2003) 870-881
22. Kampa M., Kogia C., Theodoropoulos P.A., Anezinis P., Charalampopoulos I., Papakonstanti E.A., Stathopoulos E.N., Hatzoglou A., Stournaras C., Gravanis A., and Castanas E. Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol. Cancer Ther. 5 (2006) 1342-1351
23. Gatson J.W., and Singh M. Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. Endocrinology 148 (2007) 2458-2464
24. Alimirah F., Chen J., Basrawala Z., Xin H., and Choubey D. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett. 580 (2006) 2294-2300
25. Stone K.R., Mickey D.D., Wunderli H., Mickey G.H., and Paulson D.F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer 21 (1978) 274-281
26. Mitchell S., Abel P., Ware M., Stamp G., and Lalani E. Phenotypic and genotypic characterization of commonly used human prostatic cell lines. BJU Int. 85 (2000) 932-944
27. Vardouli L., Moustakas A., and Stournaras C. LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-beta. J. Biol. Chem. 280 (2005) 11448-11457
28. Papakonstanti E.A., and Stournaras C. Tumor necrosis factor-alpha promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-gamma1 activation and actin filament redistribution. Mol. Biol. Cell 15 (2004) 1273-1286
29. Papakonstanti E.A., and Stournaras C. Actin cytoskeleton architecture and signaling in osmosensing. Methods Enzymol. 428 (2007) 227-240
30. Flusberg D.A., Numaguchi Y., and Ingber D.E. Cooperative control of Akt phosphorylation, bcl-2 expression, and apoptosis by cytoskeletal microfilaments and microtubules in capillary endothelial cells. Mol. Biol. Cell 12 (2001) 3087-3094
31. Gourlay C.W., and Ayscough K.R. Identification of an upstream regulatory pathway controlling actin-mediated apoptosis in yeast. J. Cell. Sci. 118 (2005) 2119-2132
32. Parlato S., Giammarioli A.M., Logozzi M., Lozupone F., Matarrese P., Luciani F., Falchi M., Malorni W., and Fais S. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19 (2000) 5123-5134
33. Jiang B.H., Jiang G., Zheng J.Z., Lu Z., Hunter T., and Vogt P.K. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 12 (2001) 363-369
34. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology. Nature 420 (2002) 629-635
35. Aznar S., and Lacal J.C. Rho signals to cell growth and apoptosis. Cancer Lett. 165 (2001) 1-10
36. Esteve P., Embade N., Perona R., Jimenez B., del Peso L., Leon J., Arends M., Miki T., and Lacal J.C. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway. Oncogene 17 (1998) 1855-1869
37. Benard V., Bohl B.P., and Bokoch G.M. Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J. Biol. Chem. 274 (1999) 13198-13204
38. Ren X.D., and Schwartz M.A. Determination of GTP loading on Rho. Methods Enzymol. 325 (2000) 264-272
39. Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A., Obinata T., Ohashi K., Mizuno K., and Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285 (1999) 895-898
40. Sumi T., Matsumoto K., Takai Y., and Nakamura T. Cofilin phosphorylation and actin cytoskeletal dynamics regulated by rho- and Cdc42-activated LIM-kinase 2. J. Cell Biol. 147 (1999) 1519-1532
41. Gajate C., and Mollinedo F. Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J. Biol. Chem. 280 (2005) 11641-11647
42. Soderstrom T.S., Nyberg S.D., and Eriksson J.E. CD95 capping is ROCK-dependent and dispensable for apoptosis. J. Cell Sci. 118 (2005) 2211-2223
43. Gourlay C.W., and Ayscough K.R. The actin cytoskeleton: a key regulator of apoptosis and ageing?. Nat. Rev., Mol. Cell. Biol. 6 (2005) 583-589
44. Slack J.K., Adams R.B., Rovin J.D., Bissonette E.A., Stoker C.E., and Parsons J.T. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene 20 (2001) 1152-1163
45. Itoh S., Maeda T., Shimada M., Aishima S., Shirabe K., Tanaka S., and Maehara Y. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin. Cancer Res. 10 (2004) 2812-2817
46. Tremblay L., Hauck W., Aprikian A.G., Begin L.R., Chapdelaine A., and Chevalier S. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int. J. Cancer 68 (1996) 164-171
47. Kallergi G., Mavroudis D., Georgoulias V., and Stournaras C. Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells. Mol. Med. 13 (2007) 79-88
48. Amano M., Fukata Y., and Kaibuchi K. Regulation and functions of Rho-associated kinase. Exp. Cell Res. 261 (2000) 44-51
49. Zhao Z.S., and Manser E. PAK and other Rho-associated kinases-effectors with surprisingly diverse mechanisms of regulation. Biochem. J. 386 (2005) 201-214
50. Burridge K., and Wennerberg K. Rho and Rac take center stage. Cell 116 (2004) 167-179